Status:
WITHDRAWN
Involvement of Lymphocyte Type B in Amyotrophic Lateral Sclerosis (ALS)
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Amyotrophic Lateral Sclerosis
Eligibility:
All Genders
18-100 years
Brief Summary
The involvement of Lymphocyte type B in Amyotrophic lateral sclerosis (ALS) patients will be compared to lymphocyte in healthy subjects.
Eligibility Criteria
Inclusion
- ALS patients who could sign ICF.
Exclusion
- No ALS patients age less than 18 years.
Key Trial Info
Start Date :
August 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00846560
Start Date
August 1 2008
End Date
July 1 2009
Last Update
October 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Medical center, Neurology Department
Haifa, Israel